NO934470L - Analogifremgangsmaate for fremstilling av terapeutisk aktive, mett ede, heterocykliske carboxamidderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive, mett ede, heterocykliske carboxamidderivaterInfo
- Publication number
- NO934470L NO934470L NO934470A NO934470A NO934470L NO 934470 L NO934470 L NO 934470L NO 934470 A NO934470 A NO 934470A NO 934470 A NO934470 A NO 934470A NO 934470 L NO934470 L NO 934470L
- Authority
- NO
- Norway
- Prior art keywords
- saturated
- preparation
- therapeutically active
- analogous procedure
- carboxamide derivatives
- Prior art date
Links
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 229920006395 saturated elastomer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62036950 | 1987-02-20 | ||
| JP12525987 | 1987-05-21 | ||
| JP24949987 | 1987-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO934470L true NO934470L (no) | 1988-08-22 |
| NO934470D0 NO934470D0 (no) | 1993-12-08 |
Family
ID=27289284
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880740A NO880740L (no) | 1987-02-20 | 1988-02-19 | Fremgangsmaate for fremstilling av mettede heterocykliske carboxamidderivater. |
| NO934470A NO934470D0 (no) | 1987-02-20 | 1993-12-08 | Analogifremgangsmaate for fremstilling av terapeutisk aktive, mettede, heterocyklisk e carboxamidderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880740A NO880740L (no) | 1987-02-20 | 1988-02-19 | Fremgangsmaate for fremstilling av mettede heterocykliske carboxamidderivater. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4987132A (no) |
| EP (1) | EP0279681A3 (no) |
| CN (1) | CN1030415A (no) |
| AU (2) | AU618726B2 (no) |
| DK (1) | DK86688A (no) |
| FI (1) | FI93113C (no) |
| HU (1) | HUT50335A (no) |
| NO (2) | NO880740L (no) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0350145A3 (en) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both |
| DE3928144A1 (de) * | 1989-08-25 | 1991-02-28 | Hoechst Ag | Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| NO912475L (no) * | 1990-06-27 | 1991-12-30 | Sankyo Co | Tiazolidinkarboksylsyreamidderivater med antiallergisk aktivitet, og fremgangsmaate til fremstilling derav. |
| US5470851A (en) * | 1990-06-27 | 1995-11-28 | Sankyo Company, Limited | Thiazolidinecarboxylic acid amide derivatives and their therapeutic uses |
| US5120749A (en) * | 1991-02-20 | 1992-06-09 | Abbott Laboratories | Platelet activating antagonists |
| ATE205084T1 (de) * | 1991-03-04 | 2001-09-15 | Ct For Innovative Technology | 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer |
| US5120751A (en) * | 1991-03-29 | 1992-06-09 | Abbott Laboratories | Benzoylphenyl pyridinylthiazolidine compounds as platelet activating antagonists |
| US5149704A (en) * | 1991-05-03 | 1992-09-22 | Abbott Laboratories | Platelet activating antagonists |
| FR2678265B1 (fr) * | 1991-06-27 | 1994-01-14 | Synthelabo | Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique. |
| EP0524846A1 (fr) * | 1991-06-27 | 1993-01-27 | Synthelabo | Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique |
| NO924963L (no) * | 1991-12-27 | 1993-06-28 | Sankyo Co | Pyridyltiazolidinkarboksylsyreamid-derivater og fremgangsmaate til fremstilling derav |
| GB9200210D0 (en) * | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| US5530141A (en) * | 1992-03-04 | 1996-06-25 | Center For Innovative Technology | 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| JP3298883B2 (ja) * | 1992-06-30 | 2002-07-08 | ポハン アイアン アンド スチール カンパニー リミテッド | 強力なｐａｆ拮抗剤としての新規な環式脂質誘導体 |
| US5700817A (en) * | 1992-06-30 | 1997-12-23 | Pohang Iron & Steel Co., Ltd. | Cyclic lipid derivatives as potent PAF antagonists |
| AU4566093A (en) * | 1992-07-08 | 1994-01-31 | Shell Internationale Research Maatschappij B.V. | Piperidine derivatives |
| ES2152952T3 (es) | 1992-07-13 | 2001-02-16 | Millennium Pharm Inc | 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes. |
| US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5648486A (en) * | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
| US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| WO1994004523A1 (en) * | 1992-08-21 | 1994-03-03 | Japan Tobacco Inc. | Dioxacycloalkane compound with renin-inhibiting activity |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412573D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5750565A (en) * | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
| GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| DE69820614T2 (de) * | 1997-05-30 | 2004-09-30 | Celltech Therapeutics Ltd., Slough | Entzündungshemmende tyrosin-derivate |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| WO1999043642A1 (en) | 1998-02-26 | 1999-09-02 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| GB9924862D0 (en) * | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| AU2001248553A1 (en) | 2000-04-17 | 2001-10-30 | Celltech R And D Limited | Enamine derivatives as cell adhesion molecules |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| AU2001267753A1 (en) | 2000-07-07 | 2002-01-21 | Celltech R And D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| WO2002010136A1 (en) | 2000-08-02 | 2002-02-07 | Celltech R & D Limited | 3-substituted isoquinolin-1-yl derivatives |
| EP1392662B1 (de) * | 2001-05-29 | 2009-01-07 | Bayer Schering Pharma Aktiengesellschaft | Cdk inhibitorische pyrimidine, deren herstellung und verwendung als arzneimittel |
| EP1567490B1 (en) * | 2002-12-04 | 2011-10-05 | Virginia Commonwealth University | Anti-sickling agents |
| JP4610480B2 (ja) | 2003-03-07 | 2011-01-12 | アステラス製薬株式会社 | ２，６−ジ置換スチリルを有する含窒素ヘテロ環誘導体 |
| EP1692121A1 (en) | 2003-11-18 | 2006-08-23 | University of Tennessee Research Foundation | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| US7119208B2 (en) * | 2003-12-03 | 2006-10-10 | Virginia Commonwealth University | Anti-sickling agents |
| BRPI0507500A (pt) * | 2004-02-06 | 2007-06-26 | Schering Ag | derivados de piperazina inibidores de quimiocina e seus usos para tratar mieloma múltiplo |
| UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| DK2303021T3 (en) * | 2008-06-16 | 2019-04-08 | Univ Tennessee Res Found | RELATIONSHIPS FOR TREATING CANCER |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| AR075153A1 (es) * | 2009-01-30 | 2011-03-16 | Glaxosmithkline Llc | Compuesto hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil]etil)-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2- tiofenocarboxamida en forma cristalina, composicion farmaceitica que lo comprende, procedimiento para prepararla, su uso para preparar un medicamento util para tratar o disminuir la |
| JP5879273B2 (ja) | 2010-03-01 | 2016-03-08 | ジーティーエックス・インコーポレイテッド | 癌を処置するための化合物 |
| CN104529942B (zh) * | 2014-12-10 | 2018-05-15 | 天津孚音生物科技发展有限公司 | 一种伐诺司林的合成方法 |
| AU2019271419B2 (en) | 2018-05-17 | 2022-09-29 | Bionomics Limited | Pain treating compounds and uses thereof |
| CN111057735B (zh) * | 2020-01-06 | 2021-10-15 | 浙江工业大学 | 一种解淀粉芽孢杆菌酯酶在拆分N-BOC-DL-α-氨基丁酸甲酯中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3592905A (en) | 1969-10-30 | 1971-07-13 | Merck & Co Inc | Therapeutic methods |
| FR2356423A1 (fr) | 1976-07-01 | 1978-01-27 | Oeriu Simion | Derives de l'acide thiazolidinecarboxylique, leur preparation et leur application comme medicaments |
| AU528115B2 (en) * | 1978-04-08 | 1983-04-14 | Santen Pharmaceutical Co. Ltd. | Antihypertensive 4-thiazolidine/carboxylic acids |
| EP0045281B1 (de) * | 1980-07-28 | 1985-05-08 | Ciba-Geigy Ag | Thiazolinderivate und Verfahren zu ihrer Herstellung |
| FR2541280B1 (fr) * | 1983-01-13 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent |
| JPS6090012A (ja) * | 1983-10-24 | 1985-05-21 | Nippon Mining Co Ltd | 濾過装置 |
| US4656190A (en) | 1983-11-14 | 1987-04-07 | Merck & Co., Inc. | Indene derivatives and their use as PAF-antagonists |
| GB8418424D0 (en) | 1984-07-19 | 1984-08-22 | Scras | Inhibition of platelets aggregation |
| EP0178261A3 (en) | 1984-10-10 | 1986-12-30 | Sandoz Ag | Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts |
| HU200177B (en) * | 1985-06-18 | 1990-04-28 | Biogal Gyogyszergyar | Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds |
| US4621038A (en) | 1985-06-24 | 1986-11-04 | Xerox Corporation | Photoconductive imaging members with novel symmetrical fluorinated squaraine compounds |
| DE3531498A1 (de) * | 1985-09-04 | 1987-03-05 | Bayer Ag | Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| IT1196485B (it) * | 1986-07-14 | 1988-11-16 | Zambon Spa | Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica |
| JPS63225373A (ja) * | 1986-07-24 | 1988-09-20 | Sumitomo Pharmaceut Co Ltd | 新規チアゾリジン−４−オン誘導体およびその酸付加塩 |
| DE3635744A1 (de) * | 1986-10-21 | 1988-04-28 | Bayer Ag | Substituierte aminoketale |
-
1988
- 1988-02-16 CN CN88100590.8A patent/CN1030415A/zh not_active Withdrawn
- 1988-02-18 FI FI880757A patent/FI93113C/fi not_active IP Right Cessation
- 1988-02-19 HU HU88811A patent/HUT50335A/hu unknown
- 1988-02-19 EP EP88301397A patent/EP0279681A3/en not_active Withdrawn
- 1988-02-19 DK DK086688A patent/DK86688A/da not_active Application Discontinuation
- 1988-02-19 NO NO880740A patent/NO880740L/no unknown
- 1988-02-22 AU AU12080/88A patent/AU618726B2/en not_active Ceased
- 1988-08-16 US US07/232,899 patent/US4987132A/en not_active Expired - Fee Related
-
1992
- 1992-04-01 AU AU14013/92A patent/AU646156B2/en not_active Ceased
-
1993
- 1993-12-08 NO NO934470A patent/NO934470D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI93113B (fi) | 1994-11-15 |
| FI880757A (fi) | 1988-08-21 |
| DK86688A (da) | 1988-08-22 |
| FI880757A0 (fi) | 1988-02-18 |
| EP0279681A2 (en) | 1988-08-24 |
| NO934470D0 (no) | 1993-12-08 |
| AU1401392A (en) | 1992-06-25 |
| EP0279681A3 (en) | 1989-11-15 |
| NO880740L (no) | 1988-08-22 |
| CN1030415A (zh) | 1989-01-18 |
| AU618726B2 (en) | 1992-01-09 |
| FI93113C (fi) | 1995-02-27 |
| AU1208088A (en) | 1988-08-25 |
| DK86688D0 (da) | 1988-02-19 |
| AU646156B2 (en) | 1994-02-10 |
| HUT50335A (en) | 1990-01-29 |
| NO880740D0 (no) | 1988-02-19 |
| US4987132A (en) | 1991-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934470L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, mett ede, heterocykliske carboxamidderivater | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO861481L (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive heterocykliske amid-derivater. | |
| FI905941A (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi | |
| NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| FI91152B (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO169900C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater | |
| NO176319C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater | |
| NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
| FI896249A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinijohdannaisten valmistamiseksi | |
| NO178068C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater | |
| NO176713C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater | |
| NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| NO172849C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater | |
| FI93444B (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| NO178698C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater | |
| NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO167923C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidsubstituerte heterocykliske forbindelser | |
| NO169652C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive guaninderivater | |
| NO173606C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater | |
| NO174463C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidinderivater | |
| NO177263C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater | |
| NO173330C (no) | Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater |